RETRIG
Dead / Abandoned — Abandoned — no statement of use filed (as of 28 Jul 2025)
What this means for you
This application is over — abandoned 28 Jul 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90808332
- Mark type
- Stylized text
- Filed
- 02 Jul 2021
- Published for opposition
- 26 Apr 2022
- Abandoned
- 28 Jul 2025
- Attorney of record
- Muzamil Huq
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparation, namely, a recombinant, human monoclonal antibody antigen-binding fragment designed to reverse the antiplatelet activity of ticagrelor in major bleeding and urgent surgery situations
Owner
- SFJ PHARMA X, INC., Pleasanton, CA, US
- SFJ PHARMACEUTICALS X, LTD., Pleasanton, CA, KY
- PhaseBio Pharmaceuticals, Inc., Malvern, PA, US
- PhaseBio Pharmaceuticals, Inc., Malvern, PA, US
Prosecution history
- 28 Jul 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 28 Jul 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 11 Dec 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Dec 2024 — SOU EXTENSION 5 GRANTED
- 09 Dec 2024 — SOU EXTENSION 5 FILED
- 09 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 13 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Jun 2024 — SOU EXTENSION 4 GRANTED
- 06 Jun 2024 — SOU EXTENSION 4 FILED
- 06 Jun 2024 — SOU TEAS EXTENSION RECEIVED
- 13 Jan 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Jan 2024 — SOU EXTENSION 3 GRANTED
- 21 Dec 2023 — SOU EXTENSION 3 FILED
- 12 Jan 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Jan 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP